about day 10 and involves a dramatic expansion of erythroid lineage cells in the fetal liver. This expansion is highly dependent upon Epo, the Epo receptor, and SOCS box. SOCS1 and SOCS3 share the ability to bind Cell 618
4-12 cells were injected with the H2K-SOCS3 construct, However, by in situ hybridization of E12.5 embryos, and the progeny were initially examined for founders. SOCS3 was highly expressed in the fetal liver as well Since no founders were obtained, recipient females as other ill-defined sites ( Figure 1B) . In contrast, SOCS1
were sacrificed at 12.5 days and the embryos examined. was expressed at low levels (C), while CIS was exAs illustrated in Figure 2 , embryos were observed that pressed at detectable levels in the fetal liver and other had no evidence of fetal liver erythropoiesis (3 and 4) in sites (D). The relevance of CIS expression is unknown, addition to the normal appearing embryos (1 and 2). This since CIS-deficient mice have no detectable phenotype phenotype is strikingly similar to that seen in embryos (unpublished data). deficient in either JAK2 or the Epo To further assess SOCS3 protein expression, sections receptor (Wu et al., 1995b) , both of which are associated of fetal livers from 12.5-day-old embryos were examined by immunofluorescence. To identify the erythroid prowith embryonic lethality. genitors and lineage committed cells, the sections were To establish that the lack of fetal liver erythropoiesis also exposed to an antibody against Ter119 directly was associated with the transgene, the embryos were conjugated with phycoerythrin. Ter119 is expressed on genotyped by PCR. As illustrated in Figure 2 (lower all erythroid lineage committed cells (Ikuta et al., 1990) panel), the two normally appearing embryos did not that require Epo for survival and differentiation (Wu et contain the transgene, while both embryos that lacked al., 1995b). As illustrated ( Figures 1E, 1F , and 1I), SOCS3 detectable fetal liver erythropoiesis contained the transwas highly expressed in Ter119-positive fetal liver cells gene. Among a total of 46 embryos, 38 embryos did not at day 12.5. SOCS3 was not expressed in the Ter119-contain the transgene and were phenotypically normal. negative hepatocytes within the fetal liver. The specificAmong the 8 embryos containing transgenic sequences, ity of detection is indicated by the absence of SOCS3 2 were phenotypically normal, while the remainder lacked expression in Ter119-positive fetal liver cells from a detectable fetal liver erythropoiesis. Since it would be SOCS3-deficient embryo (G). However, there was a anticipated that not all the hematopoietic stem cells great variation in the levels of SOCS3 expression in would be transduced, the results suggest that the high- The full-length SOCS3 cDNA was cloned in the pSP65-H2K-I-LTR vector to generate the transgenic construct illustrated here. Recipient foster females were sacrificed at day 12.5 of gestation, and the embryos were examined. Integration of the DNA transgenic construct was assessed by PCR using primers P H2K and P Rev . The quality of the genomic DNA template isolated from each embryo was confirmed using primers P For and P Rev (lower panel). The transgene-positive embryos (3 and 4) are characterized by the visually obvious absence of red cells in the fetal liver and surrounding tissues when compared to wildtype littermates (embryos 1 and 2).
create a completely protein null mutation. Three indeincreased with age such that after day 14, all the SOCS3-deficient embryos that had survived display erythropendently derived targeted ES clones gave rise to mutant strains, all of which had identical phenotypes. Hetcytosis. Lastly, all the SOCS3-deficient embryos are smaller than heterozygous or wild-type embryos at the erozygous mice were phenotypically normal and were bred to obtain mice homozygous for the disrupted allele. same age. The delayed development may be secondary to the erythrocytosis. As illustrated in Figure 1G , SOCS3 protein is not detectable in the homozygously deficient embryos. Typing of One consequence of the extensive erythrocytosis in the embryos might be a shift from the more immature the progeny failed to detect homozygous individuals, with one exception, indicating that deletion of the gene populations to the more mature, nonproliferative populations of cells. As illustrated in Figure 4A , such an effect resulted in an embryonic lethality. In the one exception, the pup was born runted and died within 24 hr. To estabwas observed in colony assays. The numbers of the most differentiated erythroid colony-forming cells (CFU-E) lish the period of lethality, embryos were taken at various stages of development and typed. As illustrated in Table  and the Postnatal mice and embryos were genotyped by PCR, as shown in Figure 3B . The embryos were collected between day 10.5 and 16.5 of pregnancy from SOCS3 ϩ/Ϫ females crossed to SOCS3 ϩ/Ϫ males. Histological examination of some mutant embryos revealed extensive erythrocytosis in the fetal liver (as shown in Figure 4) ; the frequency at which this phenotype was observed is indicated in the table in Figure  6C ). The data demonstrate that SOCS3 deficiency does not result in any overt alterations in T or B cell differentiation or function, although it will be important to study these cells in more detail for subtle effects in subset differentiation or function.
Discussion
The results demonstrate that SOCS3 plays a critical role in fetal liver erythropoiesis at a stage when it is highly expressed in erythroid lineage cells. The pathology seen in the absence of SOCS3 is a dramatic expansion of erythropoiesis within the fetal liver as well as throughout the embryo. Morphologically, the abnormal expansion that occurs within the fetal liver causes, in later stage embryos, a complete loss of the normal architecture of the liver (data not shown). However, the most visually (Adams et al., 1998) . Thus, the concept has emerged that SOCS proteins are feedback inhibitors of cytokine signaling. However, in none of these situations has the level of protein been examined relative to the levels that are required for inhibition of JAK function. This is particularly important, since, in our experience, the SOCS proteins turn over very rapidly in many of the cell types in which they are induced. Irrespective, the expression of SOCS3 in fetal liver cells does not require Epo receptor signaling. Two possibilities exist: namely that SOCS3 expression is developmentally regulated in a manner which is independent of cellular signaling or, alternatively, that another signaling pathway is involved. One intriguing signaling possibility is that stem cell factor, acting through c-Kit, suppresses a developmentally programmed expression of SOCS3.
The possibility that SOCS3 expression is developmentally regulated is also of considerable interest. In particular, it could be envisioned that it is the activation of SOCS3 expression at later stages of erythropoiesis that is responsible for turning off Epo signaling and promoting the cells into the terminal stages of differentiation. This possibility is consistent with the phenotype of the sites in SOCS3-deficient embryos. However, there is also an increased amount of apoptosis, and we would propose that in these embryos Epo becomes limiting recently found that SOCS3 similarly binds the activation and a significant fraction of the cells undergo apoptosis loop kinase of JAK2 and inhibits activity (Sasaki et al., prior to terminal differentiation. Remarkably, a decrease 1999). In addition to inhibiting JAK kinase activity, it is in colony-forming cells was also observed in Caspase also possible that SOCS proteins, through interaction 8-deficient embryos that have a virtually identical paof the SOCS box with the elongin BC complex (Kamura thology of erythrocytosis (Varfolomeev et al., 1998) . In et al., 1998; Zhang et al., 1999), may target the kinases contrast to the decrease in colony numbers, the numfor degradation. All these experiments, however, have bers of cells produced in the colonies are greatly inrelied on overexpression studies. It will therefore be creased. This could be due to a decreased cell cycle important to use mice genetically deficient in SOCS3 as time or to the ability of the cells to undergo more rounds well as cytokine signaling to establish the specificity of of proliferation. We favor the later possibility, although additional studies will be needed to substantiate this SOCS3 inhibition. samples. Day 9.5, 12.5, and 15.5 embryos were fixed in 10% buffered formalin, parafin embedded, and sectioned at 4 m. Slides prepared Experimental Procedures for histological analysis were stained with hematoxylin and eosin as described previously. RNA in situ hybridization was carried out on Construction of SOCS3 Targeting Vector frozen cryosections essentially as described (Angerer and Angerer, The SOCS3 gene was isolated from a 129/SVE mouse genomic 1992) using [␣-33 P]-UTP-labeled antisense cRNA probes transcribed library in EMBL3 using SOCS3 full-length cDNA probe. Positive from plasmids containing murine cDNA fragments of CIS (216 bp), clones were restriction mapped and partially sequenced. For the SOCS1 (200 bp), and SOCS3 (300 bp). Immunofluorescence was targeting construct, a 13 kb SalI/HindIII fragment was subcloned, carried out using a PE-conjugated anti-mouse TER119 antibody to followed by replacement of a 3 kb NotI/XbaI fragment containing detect numbers of erythroid progenitors in all embryonic sections. the entire SOCS3 coding region with a neomycin resistance cassette SOCS3 protein levels were detected using a rabbit polyclonal antipreviously described (van Deursen et al., 1991). A herpes simplex sera anti-SOCS3 N-terminal peptide antibody (aa 5-21 of mouse thymidine kinase (HSV-tk) cassette mediating negative selection SOCS3) and Alexa 488 -anti-rabbit polyclonal antibody (Molecular was inserted in the 3Ј-end of the SOCS3-neo construct.
Probes) as a secondary antibody. Briefly, tissue sections were refixed for 20 min in 10% buffered formalin, blocked for 1 hr in a solution of 10% BSA in 1ϫ PBS followed by incubation overnight Transfection of ES Cells and Generation of SOCS3-Deficient Mice at 4ЊC with a 1:100 dilution of primary anti-SOCS3 antibody. Slides were washed with 1ϫ PBS and incubated for a further 2 hr at room E14 (129/Ola mouse strain) ES cells were cultured as described . Twenty-five micrograms of SalI linearized temperature with a 1:100 dilution of PE-anti TER119 and Alexa 488 -anti-rabbit antibodies. Slides were washed three times with 1ϫ PBS SOCS3 plasmid construct was electroporated into the ES cells and grown under double selection as described . and mounted under coverslips using Antifade-Fluoromount (Fisher). Ter119-positive cells and SOCS3 expression levels were visualized Conditions for blastocyst injection of correctly targeted and karyotypically normal ES clones and breeding to generate mice homozyby confocal microscopy using a Leica DM-IRBE microscope together with Leica TCS-NT software. gous for the mutated SOCS3 gene were performed essentially as
